Cure Kids Ventures

Cure Kids Ventures (CKV) is a New Zealand-based venture capital firm that focuses on investing in early-stage healthcare companies with the potential to positively impact child health. Since its establishment in 2008, CKV has been dedicated to supporting innovations in medical devices, medications, diagnostics, health information, and healthcare delivery systems. The firm is wholly owned by Cure Kids Foundation, New Zealand's largest private funder of child health research, which provides CKV with deep connections to universities, research institutes, and organizations, facilitating a robust deal flow.

CKV's investment strategy centers on seed and early-stage ventures, typically investing between $200,000 and $500,000 in companies that demonstrate high growth potential and the capability to enhance child health outcomes. The firm's portfolio includes a diverse range of companies, such as Formus Labs, which offers AI-driven 3D imaging for orthopedic surgical planning, and Veriphi, a device that uses lasers to identify and verify intravenous medications. CKV's team comprises professionals with global experience in the biotech, healthcare, and medical devices industries, bringing expertise in early-stage company development, intellectual property commercialization, global expansion, science, finance, and mergers and acquisitions.

As a predominant investor in New Zealand's seed and early-stage healthcare and biotech sector, CKV has established a reputation as an informed and value-added investor. In addition to providing investment funds, the firm offers its portfolio companies healthcare industry-specific expertise and access to industry networks. CKV's commitment to improving child health is integral to Cure Kids' vision for a healthy childhood for everyone, reflecting a strong alignment between the firm's investment activities and its parent organization's mission to advance child health research and innovation.